載入...
Single-Arm Phase II Cancer Survival Trial Designs
The current practice for designing single-arm phase II trials with time-to-event endpoints is limited to using either a maximum likelihood estimate test under the exponential model or a naive approach based on dichotomizing the event time at a landmark time point. A trial designed under the exponent...
Na minha lista:
| 發表在: | J Biopharm Stat |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5223772/ https://ncbi.nlm.nih.gov/pubmed/26098141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2015.1052494 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|